More than 6% of American women developed gestational diabetes in 2008
WASHINGTON — More than 6% of women who gave birth in hospitals in the United States in 2008 had diabetes or developed gestational diabetes during pregnancy, according to a new analysis by the federal government’s Agency for Healthcare Research and Quality.
The agency found that more than a quarter million women, or 6.4%, who gave birth had the conditions that can produce risks for the mother and the baby, including risk of preterm birth and miscarriage and risk of the baby having low blood sugar, jaundice or overly large body size. Gestational diabetes usually disappears after delivery.
The analysis was based on data in the report “Hospitalizations Related to Diabetes in Pregnancy, 2008,” which uses data from the 2008 Nationwide Inpatient Sample, a database of hospital inpatient stays in all short-term, nonfederal hospitals.
Study: Drug interactions may be imminent among antidepressant users
ANN ARBOR, Mich. — Many older Americans prescribed antidepressants may be taking medication that could adversely interact with the antidepressant, a new study found.
The Thomson Reuters study — sponsored by Sanofi-Aventis and published in the American Journal for Geriatric Psychiatry — found that there are more challenges in prescribing antidepressants to older Americans. Among 39,512 new antidepressant users ages 65 years and older, 25.4% were prescribed antidepressants and another medication that could cause a major interaction, while an additional 36.1% had potential moderate interactions. The remaining 38.5% of respondents had minor or no interactions.
What’s more, the study found, the likelihood that users would have to switch antidepressants because of adverse interactions between medications was 19.5%. Many side effects reported by patients included insomnia, somnolence and drowsiness.
"We found a concerning degree of potentially harmful drug combinations being prescribed to seniors. These findings reinforce the need for clinicians to be aware of potential drug-drug interactions and the importance of close patients monitoring," said Tami Mark, the paper’s lead author and director of analytic strategies at Thomson Reuters.
Phil Keough appointed EVP, COO at Millennium Pharmacy Systems
CHICAGO — Millennium Pharmacy Systems on Friday announced the appointment of Phil Keough as EVP and COO.
"Millennium’s innovative and cost-effective medication management approach offers critically needed solutions to the long-term care market,” Keough said. “By eliminating drug waste, enhancing administrative processes and improving patient safety, Millennium is changing the face of pharmacy solutions in the marketplace.”
A 20-year pharmacy operations veteran, Keough most recently led Keoco, a consulting practice specializing in high-growth, early-stage pharmacy industry businesses. Prior to that, Keough led all pharmacy operations for CVS and later Rite Aid. Keough holds a Bachelor of Science in pharmacy from Auburn University.